SPC
ONC

Sigma Planning Corp’s BeOne Medicines Ltd ONC Stock Holding History

Sigma Planning Corp’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,005
Closed -$305K – 1421
2025
Q4 		$305K Sell
1,005
-3,208
-76% -$1.05M 0.01% 1015
2025
Q3 		$1.44M Buy
+4,213
New +$1.28M 0.04% 414

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sigma Planning Corp's ONC Position: Q1 2026 in Review

Sigma Planning Corp sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 1,005 shares — an estimated $305K sold.

Sigma Planning Corp first reported a position in ONC in Q3 2025 and held it in 2 quarters. The position peaked at $1.44M in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Sigma Planning Corp reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 1,005 BeOne Medicines Ltd shares in Q1 2026, an estimated $305K.
  • Sigma Planning Corp first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 2 quarters.
  • Sigma Planning Corp's BeOne Medicines Ltd position peaked at $1.44M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.